Managing HIV infection in patients older than 50 years
- PMID: 30348740
- PMCID: PMC6199165
- DOI: 10.1503/cmaj.171409
Managing HIV infection in patients older than 50 years
Conflict of interest statement
Competing interests: Dr. M. John Gill has served as an ad hoc member on national HIV advisory boards for ViiVhealth, Gilead and Merck. No other competing interests were declared.
Comment in
-
Feasibility of screening for anal cancer in HIV-positive people older than 50 years in Canada.CMAJ. 2019 Feb 11;191(6):E171. doi: 10.1503/cmaj.71187. CMAJ. 2019. PMID: 30745404 Free PMC article. No abstract available.
References
-
- Mocroft A, Vella S, Benfield TL, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet 1998;352:1725–30. - PubMed
-
- Mocroft A, Brettle R, Kirk O, et al. EuroSIDA study group. Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. AIDS 2002;16:1663–71. - PubMed
-
- Lewden C, Chene G, Morlat P, et al. Agence Nationale de Recherches sur le Sida et les Hepatites Virales (ANRS) CO8 APROCO-COPILOTE Study Group; Agence Nationale de Recherches sur le Sida et les Hepatites Virales (ANRS) CO3 AQUITAINE Study Group. HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population. J Acquir Immune Defic Syndr 2007;46:72–7. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical